AzTrials
AzTrials

Musculoskeletal PainKISSNCT06297447

Keeping it Simple Study (KISS)

A study testing PNE4Adults - pain science education in people with Musculoskeletal Pain and Chronic Pain, run by Bettina Eiger at 3 sites in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Problem: The number of patients living with chronic musculoskeletal (MSK) pain has steadily increased over the past decade with costs rising equally. Long-standing pain is associated with significant maladaptive beliefs about pain, psychological characteristics and associated behaviors which involve structural and… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Musculoskeletal Pain, Chronic Pain
What is being tested?
PNE4Adults - pain science education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
3 sitesDenmark
Study dates
11 Mar 2024to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients referred for rehabilitation in the municipalities Køge, Holbæk, and Solrød
  • With chronic (>3 months) musculoskeletal pain.
  • Adult patients (≥18 years) - no upper limit
  • Able to understand, speak, and write Danish.

Who cannot join

  • Known cognitive deficits (e.g., dementia).
  • Diagnosed with cancer or other serious pathologies, e.g., cauda equina.
  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids, or other drugs.
  • Neurologic or psychiatric diagnoses that hinder participation, e.g., stroke and borderline.
  • Lack of ability to cooperate.

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Bettina Eiger, PhD-student contact

+4522988906

bettinae@hst.aau.dk

Michael S. Rathleff, dr.med., PhD contact

+4522117002

mirs@hst.aau.dk

Denmark3 sites, 3 recruiting
  • Træningsenheden, Holbæk Municipality

    Holbæk, Region Sjælland, 4300

    Helle B. Hansen, PT, 72363252, helha@holb.dk

    Recruiting
  • Træningsenheden, Køge Municipality

    Køge, Region Sjælland, 4600

    Annette B. Schlaikjer, PT, +45 51 36 33 78, annette.schlaikjer@koege.dk

    Recruiting
  • Genoptræningscenteret, Solrød Municipality

    Solrød Strand, Region Sjælland, 2680

    Linda M. Blæsbjerg, PT, +4556182405, kolbl@solrod.dk

    Recruiting

Other trials in Denmark

About this study

Official title: Keeping It Simple Study (KISS) - Pain Science Education for Patients With Chronic Musculoskeletal Pain Undergoing Community-based Rehabilitation: A Multicenter Randomized Controlled Trial

Problem: The number of patients living with chronic musculoskeletal (MSK) pain has steadily increased over the past decade with costs rising equally. Long-standing pain is associated with significant maladaptive beliefs about pain, psychological characteristics and associated behaviors which involve structural and functional neurobiological characteristics which share common pathophysiological mechanisms as chronic pain. The investigators recent priority setting partnership investigated the research priorities from 1000 patients with chronic MSK pain, relatives, and clinicians. Better pain education was rated as one of the three most important research areas.

Solution: Pain science education has the potential to target maladaptive psychological and behavioral components that may contribute to the maintenance of chronic pain. The KISS project will evaluate the effect of a pain neuroscience education program (PNE4Adults) on rehabilitation outcomes in patients with chronic MSK pain. This intervention has the potential to change beliefs and behaviors surrounding pain in patients with chronic MSK pain. If this is successful in disrupting maladaptive cycles contributing to chronicity, this may improve outcomes for many thousand citizens.

Read the detailed description

Introduction: Between 20% and 33% of people across the globe live with a painful musculoskeletal (MSK) condition. Costs correspond to almost 2% of the gross domestic products of European countries, posing a challenge for health care systems across the world. Patients with chronic musculoskeletal pain have a high use of healthcare, reduced work ability, loss of productivity, and loss of quality of life. Current care guidelines underline that pain science education (PSE) is a vital part of the care delivered to people suffering from chronic pain. PSE is thought in part to attenuate central sensitization and improve self-efficacy potentially mediated through decreased pain catastrophizing and modulating nocebo-related effects. On a patient level, PSE has been shown to reduce pain catastrophizing, pain intensity, and fear-avoidance in addition to improved physical functioning, self-efficacy, and pain knowledge. Combining exercise and PSE shows greater short-term improvements in pain, disability, kinesiophobia, and pain catastrophizing compared to exercise alone and the RESTORE-trial showed the benefit of adding cognitive components. On a societal level, PSE has further shown to minimize health expenses. However, some of the proposed barriers include training of the therapist delivering the education, access to training material, time during consultation, and patients' health literacy levels. Even in Denmark, a country with a highly educated population, the prevalence of people with inadequate health literacy is high, with nearly 4 out of 10 people facing difficulties accessing, understanding, appraising, and applying health information. This underlines the need to consider novel ways of delivering PSE across all levels of health literacy.

Due to the lack of tools to facilitate PSE programs, the investigators adapted an existing pain science education program that was developed by Pas et al. (2018) (PNE4Kids) to teach children with chronic pain about the underlying biopsychosocial mechanisms contributing to pain. The adapted version, named PNE4Adults, consists of a manual for the therapist and a board game to enhance engagement and participant involvement. It provides the therapist with a clear "how-to" manual and an accessible way for patients to understand the complex concept of pain. This new PSE program may also hold promise for adult patients with low levels of health literacy and enhance learning due to its practical tools and build-in teach-back. The focus on integrating PSE into rehabilitation may enhance the therapeutic alliance needed to facilitate the patients' ability to manage their own symptoms. The investigators feasibility study in adult patients with chronic MSK pain in community-based rehabilitation (Eiger, Rathleff et al. 2024 - under review) showed that PNE4Adults was well accepted (100%) and understandable by all (100%) patients, including those with low levels of health literacy. Qualitive interviews revealed that patients (irrespective of their health literacy) acquired a deeper understanding of their own situation and their pain. This novel approach may reduce the inequality in delivering of pain education.

Purpose of Sub-project 1 The primary aim of the KISS-project is to evaluate the added effect of PSE ('PNE4Adults') to "usual care" compared to "usual care" alone in community-based rehabilitation.

The investigators hypothesis is PSE plus "usual care" will result in a larger improvement of musculoskeletal health (MSK-HQ) after 3 months (primary endpoint) compared to patients undergoing "usual care" in the municipality.

Purpose of Sub-project 2 The secondary aim is to use a process evaluation to understand how it works, and for whom the program works.

The purpose of the process evaluation is to understand how it worked and for whom, and not if it worked. The investigators will combine in-house registrations from the municipality, clinician observations, individual interviews, and focus-group interviews to answer what works for whom and under which circumstances. This will give the investigators additional insights into the novel PSE intervention, shedding light on how it induces change and uncovering any potential unintended consequences. This will support future implementation pending results.

Being tested
PNE4Adults - pain science education, Usual care
Keywords
Pain education, Musculoskeletal Pain, Chronic pain, PNE4Adults, Adults, Rehabilitation, Health literacy
Medical subject headings
Musculoskeletal Pain, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PNE4Adults - pain science educationOther

    Is formerly described under arm descriptions

  • Usual careOther

    Is formerly described under arm descriptions

Study groups in NCT06297447
Study groupRoleWhat they receive
"Usual care"Active comparator"Usual Care": The control group receives unrestricted "usual care". It could include a patient interview with individual goal setting and subsequent rehabilitation using cardio and strengthening exercises towards achieving the determined goals. It will be delivered by an authorized physiotherapist, and the intervention is determined by patient preferences, physiotherapist's clinical reasoning, and available resources.
Receives: Other: Usual care
PNE4Adults - pain science educationExperimentalPNE4Adults: In this group, the participants will receive an add-on individualized PSE in addition to the usual care with the PNE4Adults resource. The PNE4Adults session will follow the developed manual (http://www.paininmotion.be/pne4kids) and will be delivered by a physiotherapist in two sessions of each 30-45 minutes, shortly following the first meeting. Firstly, the function of a normal pain system is introduced, with examples of the pain being overly or under protective. Then, the patient teaches back giving the therapist the opportunity to evaluate the understanding and, if necessary, repeat essential key messages. Secondly, the sensitized pain system is explained. Thirdly, the subject is asked to reflect on this new information in relation to his/her own situation. Subsequently, the new knowledge is integrated in "usual care" with any additional measures that need to be included, e.g., graded exposure, stress relief, graded activity, and cognitive therapies.
Receives: Other: PNE4Adults - pain science education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Musculoskeletal Health Questionnaire (MSK-HQ)

    Musculoskeletal (MSK) Health assessed by the Musculoskeletal Health Questionnaire. Score from 0 to 56. Higher scores reflect better MSK health, and better outcome

    Measured: Primary endpoint at 3 months, additional at 6 weeks and 6 months

Secondary outcomes (10)
  1. Mean Pain intensity

    Average of two numeric rating scales (most severe pain and average pain past 24 hours). Scores from 0 to 10. Higher scores reflect more intense pain, and worse outcome.

    Measured: At 6 weeks, 3 months and 6 months

  2. Pain interference

    Pain interference subscale of Brief Pain Inventory, Score from 0 to 70, higher scores reflect more bothersome and worse outcomes.

    Measured: At 6 weeks, 3 months and 6 months

  3. Concept of pain

    Measured on the Adult Concept of Pain Inventory, Danish. Scores from 0 to 52. Higher scores reflect more alignment with contemporary pain science knowledge and better outcome.

    Measured: At 6 weeks, 3 months and 6 months

  4. Pain catastrophizing

    Measured on the Pain Catastrophizing Scale, Score from 0 to 52. Higher scores reflect worse outcomes

    Measured: At 6 weeks, 3 months and 6 months

  5. Fear of movement

    Measured on the Tampa Scale of Kinesiophobia (TSK-11), scores between 11 and 44. Higher scores reflect more fear of movement and worse outcomes

    Measured: At 6 weeks, 3 months and 6 months

  6. Patient specific functional limitation

    Patient-Specific Functional Scale, scores from 0 to 10. Higher scores reflect better outcomes

    Measured: At 6 weeks, 3 months and 6 months

  7. Patient impression of change

    Global Impression of Change Scale (GISC), From "very much improved" to "very much worse".

    Measured: At 6 weeks, 3 months and 6 months

  8. Patient satisfaction with current symptom state

    Measured with the Patient Acceptable Symptom State (PASS), Yes/No answer. No is worse outcome.

    Measured: At 6 weeks, 3 months and 6 months

  9. Pain Self-efficacy

    Pain Self-efficacy Questionnaire (PSEQ), scores from 0 to 60, higher scores reflect higher self-efficacy and better outcome.

    Measured: At 6 weeks, 3 months and 6 months

  10. Adverse events

    Any adverse events will be noted. The higher the number, the worse outcome

    Measured: "through study completion, an average of 6 months".

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2024
  2. Study start11 Mar 2024
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Multicenter randomized controlled, superiority trial with a 2-group parallel design.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06297447
Sponsor's protocol ID
N-20230073
Acronym
KISS
Status last verified
Dec 2024
First submitted
29 Feb 2024
Last updated
27 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing PNE4Adults - pain science education in people with Musculoskeletal Pain and Chronic Pain, run by Bettina Eiger at 3 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bettina Eiger, PhD-student (+4522988906, bettinae@hst.aau.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Musculoskeletal Health Questionnaire (MSK-HQ) (time frame: Primary endpoint at 3 months, additional at 6 weeks and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2024; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in